Status:
ACTIVE_NOT_RECRUITING
ADHD Remote Technology Study of Cardiometabolic Risk Factors and Medication Adherence
Lead Sponsor:
King's College London
Collaborating Sponsors:
South London and Maudsley NHS Foundation Trust
Barnet, Enfield and Haringey Mental Health NHS Trust
Conditions:
Attention Deficit Hyperactivity Disorder
Cardiovascular Diseases
Eligibility:
All Genders
18-60 years
Brief Summary
Attention-deficit/hyperactivity disorder (ADHD) is a common psychiatric disorder, with a prevalence among adults of 2.5%. The disorder is diagnosed based on impairing levels of inattentive, hyperactiv...
Eligibility Criteria
Inclusion
- Diagnosis of DSM-5 ADHD
- Aged 18-60
- Able to give informed consent for participation
- Fluent in English
- Willing and able to complete self-reported assessments via smartphone
- Willing to use either their own compatible Android phone or a study Android phone as their only smartphone during the data collection period
- Willing to wear the wearable device (EmbracePlus) during the data collection period
- Not on ADHD medication at the time of recruitment
Exclusion
- Psychosis, currently experiencing a major depressive episode, mania, drug dependence in the last six months, or a major neurological disorder
- Recent contact with psychiatric acute care (admission, crisis team or liaison team (A\&E)) in the last six months
- Any other major medical disease which might impact upon the patient's ability to participate in normal daily activities (e.g., due to hospitalisations)
- Pregnancy
- IQ \< 70
- Does not start ADHD medication following ADHD diagnosis (either due to personal choice or psychiatrist deciding not to prescribe ADHD medication)
Key Trial Info
Start Date :
July 12 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT05301673
Start Date
July 12 2022
End Date
March 1 2025
Last Update
December 16 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Vall d'Hebron Research Institute
Barcelona, Spain
2
King's College London
London, United Kingdom